ICU Medical Inc: Form 10-Q for the period ended Jun 30, 2013
Filed with the SEC on Jul 25, 2013 and accepted by EDGAR at Jul 25, 2013, 09:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-04-01 to 2013-06-30 | $78.7m | us-gaap:Revenues |
| Revenue | 6 months2013-01-01 to 2013-06-30 | $153.0m | us-gaap:Revenues |
| Cost of revenue | 3 months2013-04-01 to 2013-06-30 | $40.6m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2013-01-01 to 2013-06-30 | $78.1m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2013-04-01 to 2013-06-30 | $38.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2013-01-01 to 2013-06-30 | $74.8m | us-gaap:GrossProfit |
| Research and development | 3 months2013-04-01 to 2013-06-30 | $3.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2013-01-01 to 2013-06-30 | $5.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2013-04-01 to 2013-06-30 | $23.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2013-01-01 to 2013-06-30 | $46.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-04-01 to 2013-06-30 | $10.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-01-01 to 2013-06-30 | $23.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2013-04-01 to 2013-06-30 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2013-01-01 to 2013-06-30 | $7.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months2013-01-01 to 2013-06-30 | $16.1m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2013-04-01 to 2013-06-30 | $0.48 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2013-01-01 to 2013-06-30 | $1.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-04-01 to 2013-06-30 | $0.50 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2013-01-01 to 2013-06-30 | $1.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-04-01 to 2013-06-30 | 15,216,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2013-01-01 to 2013-06-30 | 15,147,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2013-01-01 to 2013-06-30 | $26.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2013-01-01 to 2013-06-30 | $11.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-06-30 | $170.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-06-30 | $346.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-06-30 | $451.6m | us-gaap:Assets |
| Current liabilities | At period end2013-06-30 | $28.0m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2013-06-30 | $414.6m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | At period end2013-07-10 | 14,650,573 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000883984-13-000036. Last ingested by Listed: Nov 14, 2026, 20:54 ET. Listed shows no prices and gives no investment advice.